The North American subsidiary of Amsterdam-based Royal Philips reached an agreement on a consent decree with the U.S. Department of Justice, representing the Food and Drug Administration, the company ...
AMSTERDAM (Reuters) - Health technology company Philips is suspending the manufacture of some defibrillators in the United States and will make others under heightened scrutiny following criticisms ...
LONDON — Koninklijke Philips Electronics NV (Amsterdam, The Netherlands), a leading vendor of consumer and medical products, has announced that it is recalling approximately 5,400 HeartStart FR2+ ...
OpenMarkets, a collaborative marketplace for capital medical equipment, has announced multiple providers have already taken advantage of its recently launched OpenMarkets MarketBuy for Philips ...
On November 3rd, a joint request for temporary stay was filed in the District of Massachusetts in a patent infringement case which has played out between Dutch medical electronics firm Koninklijke ...
The Philips HeartStart OnSite Defibrillator is designed to be the easiest-to-use, and most reliable defibrillator available. Available without a prescription from ActiveForever.com, the Philips ...
Royal Philips Electronics (NYSE: PHG, AEX: PHI) is introducing Philips HeartStart FR3 automated external defibrillator (AED) during Arab Health, for professional responders in the region who treat ...
On August 3, 2017, a Boston jury awarded Philips $10.4 million in damages for ZOLL’s infringement of three patents relating to automated external defibrillators. This represents only a fraction of the ...
We know what you're thinking: not another talking defibrillator, but the Q-CPR add-on to Philips' HeartStart MRx monitor/defibrillator actually happens to be the first of its kind, and was recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback